Elevated C-reactive protein to albumin ratio is a promising predictive biomarker for prognosis in patients with renal cell carcinoma

Key Points

• To evaluate the significance of the C-reactive protein to albumin ratio as a prognostic marker in renal cell carcinoma patients.
• Analyzed data from patients diagnosed with renal cell carcinoma (RCC)
• Measured levels of C-reactive protein and albumin
• Assessed the correlation between CAR and patient outcomes
• Elevated CAR strongly predicts poor prognosis in RCC patients
• Higher CAR is linked to increased risk of recurrence
• Findings support CAR as a valuable biomarker for clinical decision-making